Department of Otolaryngology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China.
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Affiliated to Capital Medical University, Beijing 100730, P.R. China.
Oncol Rep. 2020 Sep;44(3):791-797. doi: 10.3892/or.2020.7655. Epub 2020 Jun 22.
Chemotherapy, as an adjuvant therapy, utilizes drugs to treat cancer, and resistance to therapeutic drugs limits the efficacy of chemotherapy treatments. Several mechanisms have been proposed to improve the effect of tumor chemotherapy in order to overcome drug resistance. Among these, autophagy mediated by microRNAs (miRNAs) is one of the primary mechanisms. A large number of molecules targeted by miRNAs are involved in each step of the autophagic pathway. Recent advancement in chemotherapy research has revealed that miRNAs involved in the autophagy process target some of these molecules, thereby influencing the therapeutic effect of chemotherapy drugs. Thus, miRNAs appear to be potential tools or targets with which to suppress tumor growth and should be studied in further details for their clinical application against drug resistance.
化疗作为一种辅助疗法,利用药物治疗癌症,而治疗药物的耐药性限制了化疗的疗效。为了提高肿瘤化疗的效果,已经提出了几种机制来克服耐药性。其中,miRNAs(microRNAs)介导的自噬是主要机制之一。miRNAs 靶向的大量分子参与自噬途径的每一步。最近的化疗研究进展表明,参与自噬过程的 miRNAs 靶向这些分子中的一些,从而影响化疗药物的治疗效果。因此,miRNAs 似乎是抑制肿瘤生长的潜在工具或靶点,应该进一步深入研究其在对抗耐药性方面的临床应用。